XML 53 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Unaudited Condensed Consolidated Statements of Cash Flows (USD $)
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 145,292,817 $ 97,527,964
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 39,592,545 27,566,632
Gain on disposal of assets (35,000) 0
Loss on disposal of assets 374,925 2,010,463
Gain on sale of investments (12,213,259) (8,567,087)
Loss on sale of investments 647,520 714,756
Deferred income taxes 667,802 (3,024,452)
Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock 10,147,262 8,077,955
Excess tax benefits from stock-based compensation (1,403,740) (1,495,850)
Change in operating assets and liabilities:    
Accounts receivable, net (35,234,410) (10,607,330)
Inventories (5,137,710) 43,928,296
Prepaid expenses and other (7,809,607) 329,541
Accounts payable (689,646) 589,628
Accrued liabilities, excluding dividends declared 7,906,087 15,235,030
Net cash provided by operating activities 142,105,586 172,285,546
Activity in available-for-sale securities:    
Sales proceeds 55,370,528 31,899,490
Maturities and calls 0 6,250,000
Purchases (52,943,104) (51,633,929)
Plant and equipment additions (30,248,002) (24,067,012)
Proceeds from sale of plant and equipment 35,005 15,510
(Increase) decrease in other assets (683,656) (531,456)
Net cash used for investing activities (28,469,229) (38,067,397)
CASH FLOWS USED FOR FINANCING ACTIVITIES:    
Repayment of long-term debt (3,750,000) 0
Issuance of common stock from stock plan transactions 11,576,970 16,030,793
Cash dividends paid (40,808,322) (38,701,691)
Excess tax benefits from stock-based compensation 1,403,740 1,495,850
Net cash used for financing activities (31,577,612) (21,175,048)
NET INCREASE IN CASH AND CASH EQUIVALENTS 82,058,745 113,043,101
CASH AND CASH EQUIVALENTS, beginning of period 309,591,724 [1] 389,678,664
CASH AND CASH EQUIVALENTS, end of period $ 391,650,469 $ 502,721,765
[1] Note: The condensed consolidated balance sheet at December 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.